Brown Advisory’s Azora Therapeutics, Inc. Common Stock AZR Stock Holding History

Brown Advisory’s Portfolio AZR Stock Details AZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-42	Closed	-$9.11K	–	1181
2023 Q1	$9.11K	Hold	42	–	–	﹤0.01%	1203
2022 Q4	$5.6K	Hold	42	–	–	﹤0.01%	1200
2022 Q3	$9K	Hold	42	–	–	﹤0.01%	1131
2022 Q2	$35K	Hold	42	–	–	﹤0.01%	1089
2022 Q1	$52K	Hold	42	–	–	﹤0.01%	1097
2021 Q4	$70K	Hold	42	–	–	﹤0.01%	1219
2021 Q3	$112K	Hold	42	–	–	﹤0.01%	1080
2021 Q2	$66K	Hold	42	–	–	﹤0.01%	1056
2021 Q1	$63K	Hold	42	–	–	﹤0.01%	1067
2020 Q4	$44K	Hold	42	–	–	﹤0.01%	1008
2020 Q3	$58K	Hold	42	–	–	﹤0.01%	949
2020 Q2	$36K	Hold	42	–	–	﹤0.01%	934
2020 Q1	$34K	Hold	42	–	–	﹤0.01%	923
2019 Q4	$63K	Hold	42	–	–	﹤0.01%	1019
2019 Q3	$39K	Hold	42	–	–	﹤0.01%	995
2019 Q2	$44K	Hold	42	–	–	﹤0.01%	1012
2019 Q1	$89K	Buy	+42	New	+$125K	﹤0.01%	1286

Other funds holding AZR

Manchester Capital Management Manchester, Vermont $736M AUM 20.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Raffa Wealth Management Washington, District of Columbia $793M AUM 13.11% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Brown Advisory's AZR Position: Q2 2023 in Review

Brown Advisory sold out of Azora Therapeutics, Inc. Common Stock (AZR) in Q2 2023, closing a stake of 42 shares — an estimated $9.11K sold.

Brown Advisory first reported a position in AZR in Q1 2019 and held it in 17 quarters. The position peaked at $112K in Q3 2021. 20 funds tracked by Wall St. Rank hold AZR as of Q2 2023.

Brown Advisory reported no remaining Azora Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Brown Advisory sold 42 Azora Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $9.11K.
Brown Advisory first reported a position in Azora Therapeutics, Inc. Common Stock in Q1 2019 and held it in 17 quarters.
Brown Advisory's Azora Therapeutics, Inc. Common Stock position peaked at $112K in Q3 2021.
20 funds tracked by Wall St. Rank held Azora Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Brown Advisory's 13F filing for Q2 2023, filed 31 Jul 2023.